FETAL AND MATERNAL EFFECTS OF AMNIOINFUSION APPLIED DURING DELIVERY IN OLIGOHYDRAMNIOTIC MECONIUM- STAINED PREGNANCIES

Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies

Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies

Blog Article

INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies.METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study.Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group.

RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords hp victus 15-fa0031dx and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated.Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002).

Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01).In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.

01).Meconium under the oropharynx was ichnusa beer where to buy found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.

002).The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02).

DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration.Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported.

Report this page